HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

50 For 50: All Talc-Containing Cosmetic Samples Found Asbestos-Free In Latest US FDA Tests

Executive Summary

No traces of asbestos were found in each of 50 talc-based cosmetic products a contract lab tested for FDA, an improvement over 17% of samples – nine of 52 products – testing positive for the carcinogen in the agency’s previous round.

You may also be interested in...



US FDA Support For Cosmetic Allergen Labeling Has Foundation In Consumers' ‘Right To Know’

Office of Cosmetics and Colors Linda Katz emphasizes FDA sees allergen labeling as a public health issue. While many allergic reactions are minor, “consumers who are extremely or exclusively sensitive to a particular ingredient should have a right to know.”

J&J Cosmetic Talc Lawsuits Halted, $2Bn Trust Created, As Subsidiary Takes Liabilities Into Bankruptcy

Johnson & Johnson’s newly created subsidiary LTL Management LLC will take all cosmetic talc injury claims against the Johnson’s Baby Powder manufacturer into bankruptcy proceedings. J&J says the move is designed to ensure “equitable” resolution for all parties, while plaintiff’s attorneys have a decidedly different view on the matter.

US FDA Pushing For Cosmetics Industry Cooperation On Allergens, Other Priorities

The FDA’s Center for Food Safety and Applied Nutrition has a wish list for cosmetics reform legislation, but with Congress currently focused elsewhere, the agency is using its existing authority and resources to address cosmetics safety priorities while working to drive voluntary industry support.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS151879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel